- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 1.51K sh |
| Capex | FY 2024 · Dec 31, 2023 | $3.9K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$14.14M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $548.72K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $6.13M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $6.13M |
| Current Assets | FY 2024 · Dec 31, 2023 | $1.59M |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.7M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$12,509.11 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$12,509.11 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $4.77M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $14.1M |
| Net Income | FY 2024 · Dec 31, 2023 | −$18.85M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$18.87M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $8.13M |